정밀 의학 아칼라시아 적용 (PREMEDIA) (PREMEDIA)
PREcision MEDicine In Achalasia - 비경련성 식도이완불능증에 대한 짧은 맞춤형 POEM 대 표준 POEM의 다기관 무작위 비열등성 임상시험 및 경련성 식도운동장애에 대한 긴 맞춤형 POEM의 다기관 전향적 코호트 연구
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 3단계
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Elizabeth Yan, BS
- 전화번호: 312-908-1723
- 이메일: premedia.dcc@northwestern.edu
연구 연락처 백업
- 이름: Yasmin Pina, BS
- 전화번호: 312-503-6459
- 이메일: premedia.dcc@northwestern.edu
연구 장소
-
-
Arizona
-
Scottsdale, Arizona, 미국, 85259
- 아직 모집하지 않음
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, 미국, 92037
- 모병
- University of California San Diego
-
수석 연구원:
- Rena Yadlapati, MD
-
연락하다:
- Alexander Gonsalves, Lead Study Coordinator
- 전화번호: 858-246-5236
- 이메일: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, 미국, 80217
- 아직 모집하지 않음
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, 미국, 32611
- 모병
- University of Florida
-
수석 연구원:
- Peter Draganov, MD
-
연락하다:
- April Goddard, Lead Study Coordinator, PA-C
- 전화번호: 352-273-9483
- 이메일: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, 미국, 32803
- 아직 모집하지 않음
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, 미국, 30322
- 모병
- Emory University
-
수석 연구원:
- Anand Jain, MD
-
연락하다:
- Halley Fowler, Lead Study Coordinator
- 전화번호: 404-778-3184
- 이메일: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, 미국, 60611
- 모병
- Northwestern University
-
수석 연구원:
- John Pandolfino, MD
-
연락하다:
- Eric Pfannkuche, Lead Study Coordinator
- 전화번호: 312-926-4525
- 이메일: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, 미국, 21218
- 아직 모집하지 않음
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02114
- 모병
- Massachusetts General Hospital
-
연락하다:
- Madison Paylor, Lead Study Coordinator
- 전화번호: 617-726-0196
- 이메일: premedia@mgb.org
-
수석 연구원:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, 미국, 63110
- 모병
- Washington University
-
연락하다:
- Darren Nix, Lead Study Coordinator
- 전화번호: 314-273-1432
- 이메일: Premediasurgerytrial@wustl.edu
-
수석 연구원:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, 미국, 10065
- 아직 모집하지 않음
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28204
- 모병
- Atrium Health/Wake Forest
-
수석 연구원:
- Badih Elmunzer, MD
-
연락하다:
- Greg Scarola, Lead Study Coordinator
- 전화번호: (704) 355-2000
- 이메일: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, 미국, 44109
- 모병
- MetroHealth Medical Center
-
수석 연구원:
- Ronnie Fass, MD
-
연락하다:
- Stephanie Baker, Lead Study Coordinator
- 전화번호: 216-778-5736
- 이메일: premedia@metrohealth.org
-
Cleveland, Ohio, 미국, 44106
- 아직 모집하지 않음
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37232
- 모병
- Vanderbilt University Medical Center
-
수석 연구원:
- Dhyanesh Patel, MD
-
연락하다:
- Larry Raber, Lead Study Coordinator
- 전화번호: 615-322-4643
- 이메일: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, 미국, 75246
- 모병
- Baylor Scott & White Health
-
연락하다:
- Neomy Flores, Lead Study Coordinator
- 전화번호: 214-820-9704
- 이메일: premedia@bswhealth.org
-
수석 연구원:
- Vani Albertson Konda, MD
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
활성 비교기: 표준 근절개술
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
실험적: 맞춤형 짧은 근절제술
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Clinical Response-Overall
기간: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
기간: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
기간: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
기간: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
공동 작업자 및 조사자
협력자
협력자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- PREMEDIA (Pro00083748) - 01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .